179 related articles for article (PubMed ID: 24050955)
1. β-Blocker usage and colorectal cancer mortality: a nested case-control study in the UK Clinical Practice Research Datalink cohort.
Hicks BM; Murray LJ; Powe DG; Hughes CM; Cardwell CR
Ann Oncol; 2013 Dec; 24(12):3100-6. PubMed ID: 24050955
[TBL] [Abstract][Full Text] [Related]
2. Beta-blocker usage and breast cancer survival: a nested case-control study within a UK clinical practice research datalink cohort.
Cardwell CR; Coleman HG; Murray LJ; Entschladen F; Powe DG
Int J Epidemiol; 2013 Dec; 42(6):1852-61. PubMed ID: 24536096
[TBL] [Abstract][Full Text] [Related]
3. Beta-blocker usage and prostate cancer survival: a nested case-control study in the UK Clinical Practice Research Datalink cohort.
Cardwell CR; Coleman HG; Murray LJ; O'Sullivan JM; Powe DG
Cancer Epidemiol; 2014 Jun; 38(3):279-85. PubMed ID: 24786858
[TBL] [Abstract][Full Text] [Related]
4. Beta-blocker usage after malignant melanoma diagnosis and survival: a population-based nested case-control study.
McCourt C; Coleman HG; Murray LJ; Cantwell MM; Dolan O; Powe DG; Cardwell CR
Br J Dermatol; 2014 Apr; 170(4):930-8. PubMed ID: 24593055
[TBL] [Abstract][Full Text] [Related]
5. Beta-blocker subtypes and risk of low birth weight in newborns.
Duan L; Ng A; Chen W; Spencer HT; Lee MS
J Clin Hypertens (Greenwich); 2018 Nov; 20(11):1603-1609. PubMed ID: 30267456
[TBL] [Abstract][Full Text] [Related]
6. Low-dose aspirin use after diagnosis of colorectal cancer does not increase survival: a case-control analysis of a population-based cohort.
Cardwell CR; Kunzmann AT; Cantwell MM; Hughes C; Baron JA; Powe DG; Murray LJ
Gastroenterology; 2014 Mar; 146(3):700-708.e2. PubMed ID: 24239563
[TBL] [Abstract][Full Text] [Related]
7. Does Angiotensin-Converting Enzyme Inhibitor and β-Blocker Use Reduce the Risk of Primary Liver Cancer? A Case-Control Study Using the U.K. Clinical Practice Research Datalink.
Hagberg KW; Sahasrabuddhe VV; McGlynn KA; Jick SS
Pharmacotherapy; 2016 Feb; 36(2):187-95. PubMed ID: 26846893
[TBL] [Abstract][Full Text] [Related]
8. Drugs affecting the renin-angiotensin system and survival from cancer: a population based study of breast, colorectal and prostate cancer patient cohorts.
Cardwell CR; Mc Menamin ÚC; Hicks BM; Hughes C; Cantwell MM; Murray LJ
BMC Med; 2014 Feb; 12():28. PubMed ID: 24521426
[TBL] [Abstract][Full Text] [Related]
9. Propranolol and survival from breast cancer: a pooled analysis of European breast cancer cohorts.
Cardwell CR; Pottegård A; Vaes E; Garmo H; Murray LJ; Brown C; Vissers PA; O'Rorke M; Visvanathan K; Cronin-Fenton D; De Schutter H; Lambe M; Powe DG; van Herk-Sukel MP; Gavin A; Friis S; Sharp L; Bennett K
Breast Cancer Res; 2016 Dec; 18(1):119. PubMed ID: 27906047
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of different beta-blockers in the treatment of long QT syndrome.
Abu-Zeitone A; Peterson DR; Polonsky B; McNitt S; Moss AJ
J Am Coll Cardiol; 2014 Sep; 64(13):1352-8. PubMed ID: 25257637
[TBL] [Abstract][Full Text] [Related]
11. β-Blocker Use and Risk of Mortality in Heart Failure Patients Initiating Maintenance Dialysis.
Zhou H; Sim JJ; Shi J; Shaw SF; Lee MS; Neyer JR; Kovesdy CP; Kalantar-Zadeh K; Jacobsen SJ
Am J Kidney Dis; 2021 May; 77(5):704-712. PubMed ID: 33010357
[TBL] [Abstract][Full Text] [Related]
12. Beta blockers and breast cancer mortality: a population- based study.
Barron TI; Connolly RM; Sharp L; Bennett K; Visvanathan K
J Clin Oncol; 2011 Jul; 29(19):2635-44. PubMed ID: 21632503
[TBL] [Abstract][Full Text] [Related]
13. Clopidogrel use and cancer-specific mortality: a population-based cohort study of colorectal, breast and prostate cancer patients.
Hicks BM; Murray LJ; Hughes C; Cardwell CR
Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):830-40. PubMed ID: 26017274
[TBL] [Abstract][Full Text] [Related]
14. Beta-blockers for hypertension.
Wiysonge CS; Bradley HA; Volmink J; Mayosi BM; Opie LH
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002003. PubMed ID: 28107561
[TBL] [Abstract][Full Text] [Related]
15. Statin use after colorectal cancer diagnosis and survival: a population-based cohort study.
Cardwell CR; Hicks BM; Hughes C; Murray LJ
J Clin Oncol; 2014 Oct; 32(28):3177-83. PubMed ID: 25092779
[TBL] [Abstract][Full Text] [Related]
16. Metformin use and survival after colorectal cancer: A population-based cohort study.
Mc Menamin ÚC; Murray LJ; Hughes CM; Cardwell CR
Int J Cancer; 2016 Jan; 138(2):369-79. PubMed ID: 26331456
[TBL] [Abstract][Full Text] [Related]
17. Comparative effects of celiprolol, propranolol, oxprenolol, and atenolol on respiratory function in hypertensive patients with chronic obstructive lung disease.
Fogari R; Zoppi A; Tettamanti F; Poletti L; Rizzardi G; Fiocchi G
Cardiovasc Drugs Ther; 1990 Aug; 4(4):1145-9. PubMed ID: 1982059
[TBL] [Abstract][Full Text] [Related]
18. Stage-specific associations between beta blocker use and prognosis after colorectal cancer.
Jansen L; Hoffmeister M; Arndt V; Chang-Claude J; Brenner H
Cancer; 2014 Apr; 120(8):1178-86. PubMed ID: 24415516
[TBL] [Abstract][Full Text] [Related]
19. Post-diagnostic oral bisphosphonate use and colorectal cancer mortality: a population-based cohort study within the UK Clinical Practice Research Datalink.
Hicks BM; Murray LJ; Hughes C; Cardwell CR
Br J Cancer; 2015 Jun; 113(1):123-6. PubMed ID: 25989268
[TBL] [Abstract][Full Text] [Related]
20. The effect of warfarin therapy on breast, colorectal, lung, and prostate cancer survival: a population-based cohort study using the Clinical Practice Research Datalink.
O'Rorke MA; Murray LJ; Hughes CM; Cantwell MM; Cardwell CR
Cancer Causes Control; 2015 Mar; 26(3):355-66. PubMed ID: 25534917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
